CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS
· Delayed Price · Currency is USD
0.0042
+0.0002 (5.00%)
Apr 25, 2025, 1:23 PM EDT
CNBX Pharmaceuticals Employees
CNBX Pharmaceuticals had 2 employees as of August 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$295,356
Market Cap
17.84K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| Elite Pharmaceuticals | 64 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
CNBX Pharmaceuticals News
- 2 years ago - Cannabis REITs: Smoked Out - Seeking Alpha
- 2 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
- 2 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
- 2 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
- 2 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
- 2 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
- 3 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
- 3 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire